The clinical relevance of intragenic NRXN1 deletions
- 13 January 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 57 (5), 347-355
- https://doi.org/10.1136/jmedgenet-2019-106448
Abstract
Background Intragenic NRXN1 deletions are susceptibility variants for neurodevelopmental disorders; however, their clinical interpretation is often unclear. Therefore, a literature study and an analysis of 43 previously unpublished deletions are provided. Methods The literature cohort covered 629 heterozygous NRXN1 deletions: 148 in controls, 341 in probands and 140 in carrier relatives, and was used for clinical hypothesis testing. Exact breakpoint determination was performed for 43 in-house deletions. Results The prevalence of exonic NRXN1 deletions in controls was ~1/3000 as compared with ~1/800 in patients with neurodevelopmental/neuropsychiatric disorders. The differential distribution of deletions across the gene between controls and probands allowed to distinguish distinct areas within the gene. Exon 6–24 deletions appeared only twice in over 100000 control individuals, had an estimated penetrance for neurodevelopmental disorders of 32.43%, a de novo rate of 50% and segregated mainly with intellectual disability (ID) and schizophrenia. In contrast, exon 1–5 deletions appeared in 20 control individuals, had an estimated penetrance of 12.59%, a de novo rate of 32.5% and were reported with a broad range of neurodevelopmental phenotypes. Exact breakpoint determination revealed six recurrent intron 5 deletions. Conclusion Exon 6–24 deletions have a high penetrance and are mainly associated with ID and schizophrenia. In contrast, the actual contribution of exon 1–5 deletions to a neurodevelopmental/neuropsychiatric disorder in an individual patient and family remains very difficult to assess. To enhance the clinical interpretation, this study provides practical considerations for counselling and an interactive table for comparing a deletion of interest with the available literature data.Keywords
This publication has 21 references indexed in Scilit:
- Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expressionGenetics in Medicine, 2017
- Incomplete penetrance of NRXN1 deletions in families with schizophreniaSchizophrenia Research, 2014
- The Database of Genomic Variants: a curated collection of structural variation in the human genomeNucleic Acids Research, 2013
- Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literatureNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2013
- Investigation of NRXN1 deletions: Clinical and molecular characterizationAmerican Journal of Medical Genetics Part A, 2013
- Molecular Analysis of a Deletion Hotspot in the NRXN1 Region Reveals the Involvement of Short Inverted Repeats in Deletion CNVsAmerican Journal of Human Genetics, 2013
- Phenotypic spectrum and genotype–phenotype correlations of NRXN1 exon deletionsEuropean Journal of Human Genetics, 2012
- SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1Cell, 2011
- Disruption of the neurexin 1 gene is associated with schizophreniaHuman Molecular Genetics, 2008
- Mapping autism risk loci using genetic linkage and chromosomal rearrangementsNature Genetics, 2007